Claudio Bomio-Confaglia

CB

Statistics

Publications

3

Citations

265

H-Index

3

Active since

2017

Claudio Bomio-Confaglia is an author at Novartis (United States) specializing in medicinal chemistry, kras g12c inhibition, and drug discovery.

Publications per year

2017–2022

3

Publications

3